Discovery Sheds Light on Bacterial Growth in CF Lungs

Researchers have shown for the first time how bacteria can grow directly in the lungs of cystic fibrosis patients, which has provided tremendous insights into bacteria behavior and growth in chronic infections.


Vertex CF Drug Combo Significantly Improves Lung Function

Vertex Pharmaceuticals Inc says results from two Phase 3 studies of its lumacaftor-ivacaftor drug combination showed statistically significant improvements in lung function (ppFEV1) in cystic fibrosis patients (12+) who have two copies of the F508del mutation.